SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Us Bio-Tech informs about disclosure

24 Apr 2024 Evaluate
Indo Us Bio-Tech has informed that the Company does not fulfill any of the criteria of ‘Large Corporate’, as per the framework provided in the SEBI Circular and hence does not fall in the category of ‘Large Corporate’ as defined under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

108.00 -1.43 (-1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1589.25
Mangalam Global Ent 12.93
Kaveri Seed 924.50
Regaal Resources 85.04
Simran Farms 165.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×